Bm. Weiss et al., PERIOPERATIVE COURSE AND RECOVERY AFTER HEPARIN-COATED CARDIOPULMONARY BYPASS - LOW-DOSE VERSUS HIGH-DOSE HEPARIN MANAGEMENT, Journal of cardiothoracic and vascular anesthesia, 10(4), 1996, pp. 464-470
Citations number
37
Categorie Soggetti
Anesthesiology,"Peripheal Vascular Diseas","Cardiac & Cardiovascular System
Objective: To compare two heparin managements for a cardiopulmonary by
pass (CPB) procedure with heparin-coated equipment. The hypothesis was
that a lower heparin dose may reduce blood loss and homologous transf
usion requirements and influence the speed of postoperative recovery.
Design: Prospective, randomized, and open study. Setting: Operating ro
om and intensive care unit in a university hospital. Participants: Twe
nty-four patients undergoing first-time elective coronary artery surge
ry. Interventions: Heparin-coated CPB equipment (Duraflo II; Baxter-Be
ntley) was used in all patients. The study group (n = 12) received low
-dose (100 IU/kg IV and 0 to 1,000 IU/L priming; target level of activ
ated coagulation time [ACT] over 180 seconds during CPB; suction in a
red cell washing device); and the control group (n = 12) received high
-dose (300 IU/kg IV and 5,000 IU/L priming; ACT over 480 seconds; stan
dard cardiotomy suction) heparin management. Measurements and Main Res
ults: ACT remained above 200 seconds after the initial heparin dose in
the study group for the CPB duration up to 99 minutes. In 11 of 12 pa
tients in the control group, additional heparin was required during CP
B. Total doses of heparin and protamine (mean 8,017 v 50,508 IU and 83
V 325 mg, respectively; p < 0.0001), volume of homologous blood trans
fusion (median 600 v 1450 mL; p < 0.025), and blood products exposure
(median 0.5 v 5.0 units/patients; p < 0.05) were significantly lower i
n the study group. Postoperative chest drainage showed a trend to lowe
r volume loss (median 705 v 930 mL: p < 0.08) in patients managed with
low-dose heparin. Oxygenator resistance during CPB, perioperative lab
oratory analyses (oxygen and metabolic data, hematocrit, platelet coun
t, prothrombin, thrombin, activated partial thromboplastin time, fibri
nogen, D-dimers, creatine kinase, and myocardial band of creatine kina
se concentration), fluid balance, and the time periods required for ex
tubation, stay in the intensive care unit, and hospital discharge were
not different between the groups. There were no evidences of myocardi
al infarction in any of 24 patients, and all recovered after the proce
dure. Conclusion: Low-dose heparin management enabled uneventful proce
dures with heparin-coated CPB equipment, significantly decreased prota
mine and homologous blood requirements, but did not reduce chest drain
age or influence the postoperative course and recovery in patients aft
er coronary artery surgery.